BOSTON, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced a ...

BOSTON - Pyxis Oncology, Inc. (NASDAQ:PYXS) announced Tuesday that Thomas Civik has been appointed Interim Chief Executive Officer, effective immediately. Civik, who has served on the company’s board ...

BOSTON, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced a ...

"Beautiful colour and large format, all in a tiny body." Why Cinematographer James Westlake used the Blackmagic PYXIS 12K on independent feature Imagination of a Phoenix. Independent feature ...

The session was led by Chairman and CEO Valentios (Eddie) Valentis, alongside CFO & Treasurer Henry Williams. Pyxis Tankers owns and operates a fleet of six mid-sized vessels, consisting of three MR ...

Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat solid tumors. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an ...

Pyxis Tankers Inc. operates as a maritime transportation company with a focus on the tanker and dry-bulk sectors in the United States and internationally. It operates through two segments: Tanker ...

How LIFO and FIFO accounting methods impact a company's inventory outlook Carla Tardi is a technical editor and digital content producer with 25+ years of experience at top-tier investment banks and ...

Pyxis Oncology, Inc. engages in the business of developing a multi-modality portfolio of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. The ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...